ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.25
-0.40 (-7.08%)
May 19, 2026, 4:00 PM EDT - Market closed
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $59.22 million as of May 19, 2026.
Market Cap
59.22M
Enterprise Value
-55.58M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.25
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $59.22M, a decrease of -67.65%. That is a compound annual growth rate of -75.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 63.73M | -17.40% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 71.21M |
| PMV Pharmaceuticals | 68.79M |
| MediciNova | 67.93M |
| Immutep | 63.21M |
| Actuate Therapeutics | 62.69M |
| Entera Bio | 62.02M |
| Dogwood Therapeutics | 61.12M |
| TScan Therapeutics | 60.10M |